Manejo de las heridas punzantes en el contexto de atención de la salud

1 Woode Owusu M, Wellington E, Rice B, Gill ON, Ncube F & contributors. Eye of the needle. United Kingdom surveillance of significant occupational exposure to bloodborne viruses in healthcare workers. 2014. Public Health England. www.gov.uk/government/uploads/system/uploads/attachment_data/file/385300/EoN_2014_-_FINAL_CT_3_sig_occ.pdf.
2 Diprose P, Deakin CD, Smedley J. Ignorance of post-exposure prophylaxis guidelines following HIV needlestick injury may increase the risk of seroconversion. Br J Anaesth 2000;84:767-70.
3 Tarantola A, Rachline A, Konto C, Houzé S, Sabah-Mondan C, Vrillon H, et al. Occupational Plasmodium falciparum malaria following accidental blood exposure: a case, published reports and considerations for post-exposure prophylaxis. Scand J Infect Dis 2005;37:131-40.
4 Menna-Barreto M. HTLV-II transmission to a health care worker. Am J Infect Control 2006;34:158-60.
5 Günther S, Feldmann H, Geisbert TW, et al. Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis 2011;204:S785-90.
6 Expert Advisory Group on AIDS and the Advisory Group on Hepatitis. Guidance for clinical healthcare workers: protection against infection with bloodborne viruses. UK Health Departments. 1998. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4014474.pdf.
7 Department of Health. HIV post-exposure prophylaxis: guidance from the UK Chief Medical Officer’s Expert Advisory Group on AIDS. Department of Health. 2008. www.gov.uk/government/uploads/system/uploads/attachment_data/file/203139/HIV_post-exposure_prophylaxis.pdf.
8 Hawkins DA, Asboe D, Barlow K, Evans B. Seroconversion to HIV-1 following a needlestick injury despite combination post-exposure prophylaxis. J Infect 2001;43:12-5.
9 Naghavi SH, Shabestari O, Alcolado J. Post-traumatic stress disorder in trainee doctors with previous needlestick injuries. Occup Med (Lond) 2013;63:260-5.
10 Cardo DM, Culver KH, Ciesielski C, et al. A case-control study of HIV seroconversion in health-care workers after percutaneous exposure. N Engl J Med 1997;337:1485-90.
11 Yazdanpanah Y, De Carli G, Migueres B, et al. Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis 2005;41:1423-30.
12 Public Health England. Immunisation against infectious disease: the Green Book. Public Health England; 2013:161-85. www.gov.uk/government/uploads/system/uploads/attachment_data/file/263311/Green_Book_Chapter_18_v2_0.pdf.
13 General Medical Council. Consent: patients and doctors making decisions together. General Medical Council. June 2008. www.gmc-uk.org/static/documents/content/Consent_-_English_0914.pdf.
14 Thomson EC, Nastouli E, Main J, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009;23:89-93.
15 Young TN, Arens FJ, Kennedy GE, Laurie JW, Rutherford GW. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure. Cochrane Database Syst Rev 2007;1:CD002835.
16 Tsai CC, Emau P, Follis KE, et al. Effectiveness of postinoculation (R)-9-(2- phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol 1998;72:4265-73.
17 Webster D. Is HIV post-exposure prophylaxis required following occupational exposure to a source patient who is virologically suppressed on antiretroviral therapy? HIV Med 2015;16:73-5.
18 Kuhar DT, Henderson DK, Struble KA, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol2013;34:875-92.
19 Expert Advisory Group on AIDS. Updated recommendation for HIV post-exposure prophylaxis (PEP) following occupational exposure to a source with undetectable HIV viral load. Department of Health. 2013. www.gov.uk/government/uploads/system/uploads/attachment_data/file/275060/EAGA_advice_on_PEP_after_exposure_to_UD_source_Dec13.pdf.
20 Expert Advisory Group on AIDS. Changes to recommended regimen for post-exposure prophylaxis. Department of Health. 2014. www.gov.uk/government/uploads/system/uploads/attachment_data/file/351633/Change_to_recommended_regimen_for_PEP_starter_pack_final.pdf.
21 Ford N, Shubber Z, Calmy A, et al. Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review. Clin Infect Dis 2015;60(Suppl 3):S170-6.
22 University of Liverpool. Drug interaction charts. www.hiv-druginteractions.org. 29 June 2015. www.hiv-druginteractions.org/InteractionCharts.aspx.
23 Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis 2010;202:984-90.
24 English National Blood Service HCV Lookback Collation Collaborators. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program. Transfusion 2002;42:1146-53.
25 Tomkins SE, Rice BD, Roy K, Cullen B, Ncube FM. Universal treatment success among healthcare workers diagnosed with occupationally acquired acute hepatitis C. J Hosp Infect 2015;89:69-71.
26 Department of Health. Annex A: examples of UKAP advice on exposure prone procedures. Department of Health. 2010. http://webarchive.nationalarchives.gov.uk/±/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/Browsable/DH_5368137.